2 December 2025 We are approaching a paradigm where human-based in vitro systems are not only human-relevant experimental platforms for understanding disease mechanisms and developing new drugs, but also computationally integrated avatars of patient physiology. What makes digital human twins (DHT) a priority to pursue is the realisation that human diseases are heterogenous in their etiology and that the patients’ response to treatments are shaped by their age, sex, genetics,